Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate
β Scribed by J. Pascual; J. Torrealba; J. Myers; S. Tome; M. Samaniego; A. Musat; A. Djamali
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 209 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Guillain-Barre Β΄syndrome (GBS) has been rarely reported after liver transplantation and generally has good outcome. We report a liver transplant patient on FK506 (tacrolimus) who developed GBS 6 months after liver transplantation. There was no evidence of liver rejection or active infection. Despite
Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p